Brief: Bioinvent’S BI-1206 To Advance Into Expansion Stage Of Phase 1/2A Study In NHL

BioInvent International AB

03/05/2022 07:04

May 3 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT’S BI-1206 TO ADVANCE INTO EXPANSION STAGE OF
PHASE
1/2A STUDY IN NHL AFTER A PRODUCTIVE END-OF-PHASE 1 FDA MEETING
    * DATA PRESENTED SO FAR INCLUDE EARLY SIGNS OF EFFICACY
    * PHASE 2 STUDY IS EXPECTED TO START ON SCHEDULE IN H1 2023

Source text for Eikon:  ID:nMFN2ZmRgj 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))